CMS National Coverage Determination (NCD)

CMS FDG PET for Refractory Seizures Form


FDG PET for Refractory Seizures

Notes: Documentation of compliance with these conditions must be maintained by the referring physician in the patient's medical record.

Indications

(207331) Is the FDG-PET intended for pre-surgical evaluation to localize a focus of refractory seizure activity? 

Contraindications

(207332) Is the FDG-PET being used for purposes other than pre-surgical evaluation? 
Effective Date

01/28/2005

Last Reviewed

NA

Original Document

  Reference



Beginning July 1, 2001, Medicare covers FDG-PET for pre-surgical evaluation for the purpose of localization of a focus of refractory seizure activity.

Limitations: Covered only for pre-surgical evaluation.

Documentation that these conditions are met should be maintained by the referring physician in the beneficiary's medical record, as is normal business practice.

(This NCD last reviewed June 2001.)